MEDS — Meds Apotek AB Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Meds Apotek AB is a Sweden-based company primarily engaged in the online retail and pharmaceutical services industry. The Company focuses on selling prescription and over-the-counter (OTC) medicines, health and wellness products, beauty items, and pet care goods through its digital platform. The Company sells prescription and non-prescription drugs through its meds.se online store with the permission of Swedish Medical Products Agency. The pharmacy's product assortment includes also veterinary drugs, medical supplies and equipment, health and wellness supplements, personal hygiene and beauty products, as well as selected food items. The Company aims to provide fast and convenient access to pharmaceutical and wellness products with home delivery and professional support from licensed pharmacists.
Directors
- Last Annual
- Last Interim
- Incorporated
- December 22nd, 2016
- Public Since
- September 23rd, 2025
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
OMX Nordic Exchange Stockholm

- Address
- Drivhjulsvagen 42 4Tr, HAGERSTEN, 126 30
- Web
- https://www.meds.se/
- Phone
- +46 842845510
- Auditors
Similar to MEDS
Apotea AB (publ)
OMX Nordic Exchange Stockholm
Axfood AB
OMX Nordic Exchange Stockholm
EQL Pharma AB
OMX Nordic Exchange Stockholm
Herno Gin AB
OMX Nordic Exchange Stockholm
Newbury Pharmaceuticals AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 21:59 UTC, shares in Meds Apotek AB are trading at SEK54.50. This share price information is delayed by 15 minutes.
Shares in Meds Apotek AB last closed at SEK54.50 and the price had moved by over the past 365 days. In terms of relative price strength the Meds Apotek AB share price has matched the FTSE Global All Cap Index by over the past year.
There is no consensus recommendation for this security.
Find out moreMeds Apotek AB does not currently pay a dividend.
Meds Apotek AB does not currently pay a dividend.
Meds Apotek AB does not currently pay a dividend.
To buy shares in Meds Apotek AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK54.50, shares in Meds Apotek AB had a market capitalisation of .
Here are the trading details for Meds Apotek AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: MEDS
Based on an overall assessment of its quality, value and momentum Meds Apotek AB is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Meds Apotek AB. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of SEK54.50, shares in Meds Apotek AB were trading -2.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Meds Apotek AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK54.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Meds Apotek AB's directors